Skip to main content

Part of the book series: ESACT Proceedings ((ESACT,volume 5))

  • 927 Accesses

Abstract

Transient gene expression systems in mammalian cells continue to grow in popularity due to their capacity to produce significant amounts of recombinant protein in a rapid and scalable manner, without the lengthy time periods and resources required for stable cell line development. In this report, we demonstrate enhanced, high-level monoclonal antibody (mAb) titres of 136 mg/L with CHO cells using the episomal-based transient expression system, Epi-CHO. These high titres were achieved by implementing an optimised transfection protocol and through screening of a variety of chemically defined and serum-free media for their ability to support elevated and prolonged viable cell densities post-transfection, and in turn, improve recombinant protein yields. The Epi-CHO system allows for scalable and rapid production of CHO cell-derived recombinant proteins in serum-free conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Geisse S. 2009. Reflections on more than 10 years of TGE approaches. Protein Expr Purif 64(2):99–107.

    Article  PubMed  CAS  Google Scholar 

  • Kunaparaju R, Liao M, Sunstrom NA. 2005. Epi-CHO, an episomal expression system for recombinant protein production in CHO cells. Biotechnol Bioeng 91(6):670–777.

    Article  PubMed  CAS  Google Scholar 

  • Matasci M, Hacker DL, Baldi L, Wurm FM. 2008. Recombinant therapeutic protein production in cultivated mammalian cells: current status and future prospects. Drug Discov Today: Technol 5(2–3):e37–e42.

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Karen Hughes and the NCRIS Biologics Facility at the AIBN and Robert Simpson from the Real-time PCR Facility at The University of Queensland.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Trent P. Munro .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media B.V.

About this paper

Cite this paper

Codamo, J., Munro, T.P., Hughes, B.S., Song, M., Gray, P.P. (2012). An Optimised Transfection Platform for the Epi-CHO Transient Expression System in Serum-free Media. In: Jenkins, N., Barron, N., Alves, P. (eds) Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT), Dublin, Ireland, June 7-10, 2009. ESACT Proceedings, vol 5. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0884-6_3

Download citation

Publish with us

Policies and ethics